Skip to main content

Find Clinical Trials

Home
Conditions
CD55-deficient Protein-losing Enteropathy

Clinical trial condition

CD55-deficient Protein-losing Enteropathy

Explore clinical trials studying CD55-deficient Protein-losing Enteropathy. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

CD55-deficient Protein-losing Enteropathy trial results

Completed

Open-Label Efficacy and Safety Study of Pozelimab in Patients With CD55-Deficient Protein-Losing Enteropathy (CHAPLE Disease)

NCT04209634

Conditions: CD55-deficient Protein-losing Enteropathy, CHAPLE, Digestive System Diseases, +3 more
Locations: Regeneron Research Site Bethesda, Maryland, United States

Regeneron Research Site Pathum Wan, Bangkok, Thailand

Regeneron Research Site Istanbul, Turkey (Türkiye)

View Trial Details